close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Weight loss drug Wegovy is from Europe — but users in the region face a long and costly wait
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Eli Lilly and Co
From CNBC.com News
Eli Lilly to acquire obesity drug maker Versanis for $1.9 billion
Tags Eli Lilly and Co Novo Nordisk A/S Health & Science
From CNBC.com News
Uninsured Americans pay high costs for an insulin Eli Lilly vowed to price at $25, Sen. Warren says
Tags Biotech and Pharmaceuticals Diabetes US: News
From CNBC.com News
EU expands Wegovy, Ozempic probe over suicide risks to include other weight loss, diabetes drugs
Tags Biotech and Pharmaceuticals US: News Diabetes
From CNBC.com News
Few patients continue weight loss drugs like Wegovy after a year — but health costs soar for all
Tags Health care industry Breaking news Obesity
From CNBC.com News
Stocks making the biggest moves midday: Shutterstock, Newell Brands, Zillow and more
Tags Markets Market Insider WD/40 Co
From CNBC.com News
European regulator to review weight-loss drugs following reports of suicidal thoughts
Tags Health Care Supplies Novo Nordisk A/S Pharmaceuticals
From CNBC.com News
Moderna strikes deal to develop mRNA drugs in China
Tags Biotechnology Pfizer Inc Health care industry
From CNBC.com News
People should stop taking Ozempic, Wegovy obesity drugs before surgery, doctors group says
Tags US: News Companies Weight management
From CNBC.com News
As drugmakers race to develop the next big weight loss pill, Eli Lilly may have an edge
Tags Health & Science Novo Nordisk A/S Eli Lilly and Co
From CNBC.com News
Eli Lilly experimental obesity drug helped patients lose up to 24% of their weight, study says
Tags Eli Lilly and Co Novo Nordisk A/S Health & Science
From CNBC.com News
Novo Nordisk says high-dose experimental obesity pill leads to 15% weight loss
Tags Health & Science Eli Lilly and Co Novo Nordisk A/S
From CNBC.com News
Pfizer to end development of experimental obesity pill due to elevated liver enzymes
Tags Companies US: News Weight management
From CNBC.com News
Novo Nordisk sues clinics allegedly selling knockoff versions of Ozempic and Wegovy
Tickers LAW LAWS
Tags Health & Science Novo Nordisk A/S Biotech and Pharmaceuticals
From CNBC.com News
Pfizer oral weight loss drug may be as effective as, quicker than Ozempic injection by Novo Nordisk, study says
Tags Health & Science Novo Nordisk A/S Drug trials
From CNBC.com News
Eli Lilly CEO vows not to raise insulin prices again, while Novo Nordisk and Sanofi hedge
Tags Biotech and Pharmaceuticals US: News Diabetes
From CNBC.com News
Novo Nordisk cuts some U.S. supply of Wegovy obesity drug as demand soars
Tags Drugs Medicine Business News
From CNBC.com News
Obesity drug industry could be worth $200 billion within the decade, says Barclays, as market valuations grow
Tags Novo Nordisk A/S Eli Lilly and Co Biotechnology
From CNBC.com News
Eli Lilly says obesity drug tirzepatide resulted in weight loss of up to 34 pounds
Tags Epidemics Politics Pandemics
From CNBC.com News
Eli Lilly, Novo Nordisk and Sanofi CEOs to testify before Senate on lowering insulin prices
Tags Congress Pandemics Epidemics
From CNBC.com News
Senate legislation would cap insulin at $35 per month for people with private insurance
Tags Breaking News: Business US Top News and Analysis Policy
From CNBC.com News
Stocks making the biggest moves midday: Apple, Tesla, Netflix, Bed Bath & Beyond & more
Tags Stock markets Progressive Corp Breaking News: Markets
From CNBC.com News
Stocks making the biggest premarket moves: Delta, First Solar, Steve Madden & more
Tags Economy Market Insider Markets
From CNBC.com News
Health misinformation is lowering U.S. life expectancy, FDA Commissioner Robert Califf says
Tags Health care industry Pharmaceuticals US: News
From CNBC.com News
People taking obesity drugs Ozempic and Wegovy gain weight once they stop medication
Tags Biotechnology Business News Business
From CNBC.com News
Sanofi to slash U.S. insulin prices in 2024 after similar cuts by Eli Lilly and Novo Nordisk
Tags Pharmaceuticals Biotech and Pharmaceuticals US: News
From CNBC.com News
Novo Nordisk to slash U.S. insulin prices by up to 75%, following move by Eli Lilly
Tags US: News Biotech and Pharmaceuticals Pharmaceuticals
From CNBC.com News
Biden proposal to cap all insulin prices at $35 a month has little chance of passing Congress
Tags CVS Health Corp Breaking News: Business US Top News and Analysis
From CNBC.com News
Trending billionaire and celebrity GLP-1 weight loss drugs are about to enter more American homes
Tags Novo Nordisk A/S Technology Health & Science
From CNBC.com News
Cramer's lighting round: Stay away from Blackline
Tags Blackline Inc Stock markets Novo Nordisk A/S
From CNBC.com News
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.